/
HCPHY
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Revenue | $646.7M | $524.5M | $546.6M | $487.7M |
| Cost of revenue | $527.1M | $446.7M | $445.6M | $429.9M |
| Gross profit | $119.6M | $77.8M | $101.0M | $57.8M |
| Gross margin | 18.5% | 14.8% | 18.5% | 11.8% |
| R&D | $727.8K | $751.0K | $1.0M | $856.3K |
| Operating income | $95.3M | $55.6M | $72.4M | $35.2M |
| EBITDA | $5.40B | $102.0M | $112.7M | $59.8M |
| Net income | $69.3M | $41.6M | $52.0M | $941.8M |
| Net margin | 10.7% | 7.9% | 9.5% | 193.1% |
| EPS (diluted) | 27.00 | 16.00 | 20.00 | 6.50 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Held by traders on TradeandTell
No one on the platform currently holds HCPHY.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HCPHY as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HCPHY yet.